<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04213716</url>
  </required_header>
  <id_info>
    <org_study_id>ENDO-CU-2014-9-14</org_study_id>
    <nct_id>NCT04213716</nct_id>
  </id_info>
  <brief_title>Comparison of the Efficacy of Calcium Hydroxide With Silver Nanoparticle and Conventional Calcium Hydroxide Intra Canal Medications on Post-Operative Pain in Symptomatic Root Canal Treatment Failure Cases:</brief_title>
  <acronym>CSNIMSRRT</acronym>
  <official_title>Comparison of the Efficacy of Calcium Hydroxide Combined With Silver Nano Particulate and Conventional Calcium Hydroxide Intra Canal Medications on Post-Operative Pain in Symptomatic Root Canal Treatment Failure Cases: A Randomized Clinical Trial Therapeutic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to measure and compare the effectiveness of nanosilver combined
      calcium hydroxide and conventional calcium hydroxide intracanal medications in reducing
      postoperative pain in patients with Symptomatic Root Canal treatment Failure .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  After confirming the diagnosis and making sure that the patient conforms to all
           eligibility criteria, the principal investigator will enroll the patient in the study.

        -  The operator will complete treatment of all cases in two visits as follows:

             1. First session:

                  -  Patients will be asked to rate their pain level on NRS before treatment is
                     started.

                  -  Patient will be anesthetized by using nerve block local anesthesia or
                     infiltration local anesthesia according to the tooth location in mandibular or
                     maxillary arch respectively.

                  -  Previous coronal restoration will be removed:

                       -  If the access will be cut through metal (amalgam alloy or cast metal) or
                          composite resin, carbide fissure bur will be used.

                       -  In case of porcelain fused to metal (PFM) crown a round diamond is used
                          to cut through the porcelain layer, then Transmetal bur is used to cut
                          through and remove the core material.

                  -  Teeth will be isolated with rubber dam.

                  -  Gutta percha removal will be done using protaper rotary retreatment files in
                     the following manner D1 has a cutting tip to facilitate initial penetration
                     into the filling material (coronal third). D2 and D3 both have non-cutting
                     tips and are used to remove material from the middle and apical thirds,
                     respectively using gutta percha solvent

                  -  Working length will be determined using an electronic apex locator then
                     confirmed with intraoral periapical radiograph, to be 0.5-1 mm, shorter than
                     radiographic apex.

                  -  Cleaning and shaping will be done using crown down preparation technique with
                     the use of protaper rotary files in an endodontic motor according to the
                     manufacturer instructions, the canals will be thoroughly irrigated using 3ml
                     of 2.5% Sodium hypochlorite between every subsequent instruments.

                  -  MD-Chelcream will be used as lubricant during mechanical preparation.

                  -  After instrumentation of the canals paper points (Protaper Paper Points) will
                     be used for drying.

                  -  Using Lentulo Spiral Filler, medicaments will be placed under aseptic
                     conditions into the canals according to each group, Experimental group Ca (OH)
                     2 ( Ca (OH) 2with nanosilver suspension and comparison group Ca (OH) 2 with
                     sterile water then access cavity will be closed with a temporary filling

                  -  Patient will be instructed to call in case of severe pain in between visits,
                     an emergency analgesics are to be prescribed to the patient (Brufen 400mg)

             2. Second session:

                  -  After 7 days, rubber dam will be placed , the temporary fillings will be
                     removed and master apical file will be introduced in each root canal to loosen
                     medicament and to create a space for subsequent irrigant, then each root canal
                     will be washed with 5 mL of sterile saline, irrigated with 1 mL of 20% citric
                     acid and again irrigated with 5 mL sterile saline.

                  -  Dryness of the canals by paper points (Protaper Paper Points).

                  -  Obturation will be carried out using the cold lateral condensation technique
                     with protaper gutta percha cones and resin sealer with spreader size according
                     to master cone size , its depth short 2 mm of the working length, and
                     auxiliary cones size 25.

                  -  After obturation a cotton pellet will be placed in the pulp chamber and the
                     access cavity will be closed with a temporary filling to avoid coronal
                     leakage.

                  -  The patient is given a NRS and asked to rate his pain level at 6, 12, 24 &amp; 48
                     hours after root canal retreatment .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2015</start_date>
  <completion_date type="Actual">December 12, 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Interventions: (60) Intracanal medication of 1ml combined nanosilver particle solution 30ppm / 100 mg calcium hydroxide Control : (60) Intracanal medication of 100 mg powder of calcium hydroxide mixed with 1ml distilled water</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>Bottles of nanosilver solution &amp; distalled water will be covered and coded either A or B by assistant supervisor, and then given to the operator.
Participants will be blinded as regard to either intervention or control Participant and operator who is also the outcome assessor are blinded.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain using a pain-measuring scale</measure>
    <time_frame>[ Time Frame:6 hours ]</time_frame>
    <description>Postoperative pain is measured using the Numerical Rating Scale (NRS) which is an 11-point scale from 0-10 where 0 represents no pain and 10 represents the worst pain measured 6 hours after the second visit (after obturation)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain using a pain-measuring scale</measure>
    <time_frame>[ Time Frame: 12 hours ]</time_frame>
    <description>Postoperative pain is measured using the Numerical Rating Scale (NRS) which is an 11-point scale from 0-10 where 0 represents no pain and 10 represents the worst pain measured 12 hours after the second visit (after obturation)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain using a pain-measuring scale</measure>
    <time_frame>[ Time Frame: 24 hours ]</time_frame>
    <description>Postoperative pain is measured using the Numerical Rating Scale (NRS) which is an 11-point scale from 0-10 where 0 represents no pain and 10 represents the worst pain measured 24 hours after the second visit (after obturation)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Postoperative pain using a pain-measuring scale</measure>
    <time_frame>[ Time Frame: 48 hours ]</time_frame>
    <description>Postoperative pain is measured using the Numerical Rating Scale (NRS) which is an 11-point scale from 0-10 where 0 represents no pain and 10 represents the worst pain measured 48 hours after the second visit (after obturation)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Retreatment</condition>
  <condition>Root Canal Retreatment</condition>
  <condition>Nonsurgical Retreatment</condition>
  <condition>Endodontic Failure</condition>
  <condition>Symptomatic Endodontic Failure</condition>
  <condition>Nanosilver</condition>
  <condition>Intracanal Medicament</condition>
  <condition>Intracanal Dressing</condition>
  <condition>AgNPs</condition>
  <condition>Calcium Hydroxide</condition>
  <condition>Ca (OH)2</condition>
  <condition>Discomfort</condition>
  <condition>Pain</condition>
  <condition>Flare up</condition>
  <condition>Postoperative</condition>
  <condition>Ache</condition>
  <condition>Post-operative</condition>
  <condition>Post Obturation</condition>
  <arm_group>
    <arm_group_label>intracanal medication</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After instrumentation of the canals and drying , using Lentulo Spiral Filler medicaments will be placed under aseptic conditions into the canals experimental Intracanal medication of 1ml of nanosilver solution 30ppm concentration mixed with 100 mg of calcium hydroxide powder used as intracanal medication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intracanal medicament</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After instrumentation of the canals and drying , using Lentulo Spiral Filler comparator intracanal medicaments will be placed under aseptic conditions into the canals which is 100 mg Ca (OH) 2 mixed with 1ml sterile water</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>silver nano particulate solution mixed with calcium hydroxide powder</intervention_name>
    <description>1ml of nanosilver solution 30ppm concentration mixed with 100 mg of calcium hydroxide powder used as intracanal medication</description>
    <arm_group_label>intracanal medication</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>conventional calcium hydroxide</intervention_name>
    <description>1ml of distilled water mixed with 100 mg of calcium hydroxide powder and used as intracanal medication after root canal retreatment</description>
    <arm_group_label>intracanal medicament</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medically free patients.

          -  Patient's age between 25-50 years.

          -  Anterior or premolar teeth diagnosed clinically and radio graphically as symptomatic
             root canal treatment failure.

          -  Positive patient's acceptance for participation in the study.

          -  Sex include both male and female.

          -  Patients who can understand Numerical Rating Scale (NRS)

          -  Patients able to sign informed consent.

        Exclusion Criteria:

          -  Pregnancy or lactation.

          -  Medically compromised patients.

          -  Patient with multiple teeth that required retreatment to eliminate the possibility of
             pain referral.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rawda baghdady, M.S.c</last_name>
    <role>Principal Investigator</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jealan El shafei, professor</last_name>
    <role>Study Director</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alaa El baz, assist prof</last_name>
    <role>Study Chair</role>
    <affiliation>faculty of dentistry Cairo university</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Endodontic Department , Faculty of Dentistry , Cairo University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Siqueira JF Jr. Aetiology of root canal treatment failure: why well-treated teeth can fail. Int Endod J. 2001 Jan;34(1):1-10. Review.</citation>
    <PMID>11307374</PMID>
  </reference>
  <reference>
    <citation>Daokar DS, Kalekar DA &quot;Endodontic Failures-A Review,&quot; Journal of Dental and Medical Sciences 4(5): 5-10, 2013</citation>
  </reference>
  <reference>
    <citation>Siqueira JF Jr, Rôças IN, Favieri A, Machado AG, Gahyva SM, Oliveira JC, Abad EC. Incidence of postoperative pain after intracanal procedures based on an antimicrobial strategy. J Endod. 2002 Jun;28(6):457-60.</citation>
    <PMID>12067129</PMID>
  </reference>
  <reference>
    <citation>Peciuliene V, Reynaud AH, Balciuniene I, Haapasalo M. Isolation of yeasts and enteric bacteria in root-filled teeth with chronic apical periodontitis. Int Endod J. 2001 Sep;34(6):429-34.</citation>
    <PMID>11556508</PMID>
  </reference>
  <reference>
    <citation>Gama TG, de Oliveira JC, Abad EC, Rôças IN, Siqueira JF Jr. Postoperative pain following the use of two different intracanal medications. Clin Oral Investig. 2008 Dec;12(4):325-30. doi: 10.1007/s00784-008-0199-3. Epub 2008 Apr 10.</citation>
    <PMID>18401602</PMID>
  </reference>
  <reference>
    <citation>Singh RD, Khatter R, Bal RK, Bal CS. Intracanal medications versus placebo in reducing postoperative endodontic pain--a double-blind randomized clinical trial. Braz Dent J. 2013;24(1):25-9.</citation>
    <PMID>23657409</PMID>
  </reference>
  <reference>
    <citation>Kawashima N, Wadachi R, Suda H, Yeng T, Parashos P. Root canal medicaments. Int Dent J. 2009 Feb;59(1):5-11. Review.</citation>
    <PMID>19323305</PMID>
  </reference>
  <reference>
    <citation>Wu D, Fan W, Kishen A, Gutmann JL, Fan B. Evaluation of the antibacterial efficacy of silver nanoparticles against Enterococcus faecalis biofilm. J Endod. 2014 Feb;40(2):285-90. doi: 10.1016/j.joen.2013.08.022. Epub 2013 Oct 1.</citation>
    <PMID>24461420</PMID>
  </reference>
  <reference>
    <citation>M. Mustafa, D. Jain, M. Kadri and etal. , &quot; Role of Calcium Hydroxide in Endodontics : A Review,&quot; Global Journal of Medical and Public Health,vol. 1, no. 1, pp. 53-57, 2012.</citation>
  </reference>
  <reference>
    <citation>Silveira CF, Cunha RS, Fontana CE, de Martin AS, Gomes BP, Motta RH, da Silveira Bueno CE. Assessment of the antibacterial activity of calcium hydroxide combined with chlorhexidine paste and other intracanal medications against bacterial pathogens. Eur J Dent. 2011 Jan;5(1):1-7.</citation>
    <PMID>21311611</PMID>
  </reference>
  <reference>
    <citation>Pacios MG, Silva C, López ME, Cecilia M. Antibacterial action of calcium hydroxide vehicles and calcium hydroxide pastes. J Investig Clin Dent. 2012 Nov;3(4):264-70. doi: 10.1111/j.2041-1626.2012.00147.x.</citation>
    <PMID>23129141</PMID>
  </reference>
  <reference>
    <citation>Vianna ME, Gomes BP, Sena NT, Zaia AA, Ferraz CC, de Souza Filho FJ. In vitro evaluation of the susceptibility of endodontic pathogens to calcium hydroxide combined with different vehicles. Braz Dent J. 2005;16(3):175-80. Epub 2006 Jan 12.</citation>
    <PMID>16429180</PMID>
  </reference>
  <reference>
    <citation>Yoldas O, Topuz A, Isçi AS, Oztunc H. Postoperative pain after endodontic retreatment: single- versus two-visit treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Oct;98(4):483-7.</citation>
    <PMID>15472665</PMID>
  </reference>
  <reference>
    <citation>Adl A, Hamedi S, Sedigh Shams M, Motamedifar M, Sobhnamayan F. The ability of triple antibiotic paste and calcium hydroxide in disinfection of dentinal tubules. Iran Endod J. 2014 Spring;9(2):123-6. Epub 2014 Mar 8.</citation>
    <PMID>24688581</PMID>
  </reference>
  <reference>
    <citation>Cwikla SJ, Bélanger M, Giguère S, Progulske-Fox A, Vertucci FJ. Dentinal tubule disinfection using three calcium hydroxide formulations. J Endod. 2005 Jan;31(1):50-2.</citation>
    <PMID>15614007</PMID>
  </reference>
  <reference>
    <citation>Javidi M, Afkhami F, Zarei M, Ghazvini K, Rajabi O. Efficacy of a combined nanoparticulate/calcium hydroxide root canal medication on elimination of Enterococcus faecalis. Aust Endod J. 2014 Aug;40(2):61-5. doi: 10.1111/aej.12028. Epub 2013 May 12.</citation>
    <PMID>25244219</PMID>
  </reference>
  <reference>
    <citation>Mei L, Lu Z, Zhang W, Wu Z, Zhang X, Wang Y, Luo Y, Li C, Jia Y. Bioconjugated nanoparticles for attachment and penetration into pathogenic bacteria. Biomaterials. 2013 Dec;34(38):10328-37. doi: 10.1016/j.biomaterials.2013.09.045. Epub 2013 Sep 30.</citation>
    <PMID>24090838</PMID>
  </reference>
  <reference>
    <citation>Mohammadi Z, Soltani MK, Shalavi S. An update on the management of endodontic biofilms using root canal irrigants and medicaments. Iran Endod J. 2014 Spring;9(2):89-97. Epub 2014 Mar 8. Review.</citation>
    <PMID>24688576</PMID>
  </reference>
  <reference>
    <citation>Imura N, Zuolo ML. Factors associated with endodontic flare-ups: a prospective study. Int Endod J. 1995 Sep;28(5):261-5.</citation>
    <PMID>8626209</PMID>
  </reference>
  <reference>
    <citation>Seltzer S, Naidorf IJ. Flare-ups in endodontics: I. Etiological factors. 1985. J Endod. 2004 Jul;30(7):476-81; discussion 475.</citation>
    <PMID>15220641</PMID>
  </reference>
  <reference>
    <citation>Siqueira JF Jr. Microbial causes of endodontic flare-ups. Int Endod J. 2003 Jul;36(7):453-63. Review.</citation>
    <PMID>12823700</PMID>
  </reference>
  <reference>
    <citation>Sathorn C, Parashos P, Messer H. Antibacterial efficacy of calcium hydroxide intracanal dressing: a systematic review and meta-analysis. Int Endod J. 2007 Jan;40(1):2-10. Review.</citation>
    <PMID>17209826</PMID>
  </reference>
  <reference>
    <citation>Calişkan MK. Nonsurgical retreatment of teeth with periapical lesions previously managed by either endodontic or surgical intervention. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Aug;100(2):242-8.</citation>
    <PMID>16037783</PMID>
  </reference>
  <reference>
    <citation>Del Fabbro M, Taschieri S, Testori T, Francetti L, Weinstein RL. Surgical versus non-surgical endodontic re-treatment for periradicular lesions. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD005511. Review. Update in: Cochrane Database Syst Rev. 2016 Oct 19;10 :CD005511.</citation>
    <PMID>17636803</PMID>
  </reference>
  <reference>
    <citation>Trope M. Relationship of intracanal medicaments to endodontic flare-ups. Endod Dent Traumatol. 1990 Oct;6(5):226-9.</citation>
    <PMID>2133314</PMID>
  </reference>
  <reference>
    <citation>Gomes-Filho JE, Silva FO, Watanabe S, Cintra LT, Tendoro KV, Dalto LG, Pacanaro SV, Lodi CS, de Melo FF. Tissue reaction to silver nanoparticles dispersion as an alternative irrigating solution. J Endod. 2010 Oct;36(10):1698-702. doi: 10.1016/j.joen.2010.07.007. Epub 2010 Aug 24.</citation>
    <PMID>20850681</PMID>
  </reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 21, 2019</study_first_submitted>
  <study_first_submitted_qc>December 26, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2019</study_first_posted>
  <last_update_submitted>December 27, 2019</last_update_submitted>
  <last_update_submitted_qc>December 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Rawda Mohammad Abdel Rahman Baghdady</investigator_full_name>
    <investigator_title>cairo egypt</investigator_title>
  </responsible_party>
  <keyword>Keywords provided by rawda mohammad abdel rahman baghdady, Cairo University:</keyword>
  <keyword>root canal retreatment</keyword>
  <keyword>calcium hydroxide</keyword>
  <keyword>distilled water</keyword>
  <keyword>silver nanoparticles</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

